The proinflammatory cytokines interleukin-1(IL -10) and tumor necrosis factor-a (TNF-a) play an important role in the pathophysiology of sepsis [1] . TNF-a and IL-i/3 con centrations are increased early in sepsis, and clinical studies demonstrate that high concentrations ofTNF-a in the circu lation correlate with the seventy of the disease and with a poor prognosis [2, 3] . Treatment with anti-TNF-a antibod ies attenuates the lethal effects of endotoxin in mice and protects against shock after infusion of gram-negative bacte ria in primates [4, 5] . Similarly, treatment with either of the naturally occurring antagonists of IL-1 and TNF, IL-1 recep tor antagonist and soluble TNF receptor (sTNFR), has been shown effective in lethal endotoxemia and in various models of experimental infection [6] [7] [8] [9] [10] [11] , TNF-a also appears to have an important role in experimental Candida albicans in fection. The mannoprotein constituents of the Candida cell wall induce the in vitro production of TNF-a by macro phages [12] , and in vivo infusion of C, albicans in mice in duces a rise in TNF-a plasma concentrations, which peak at Pentoxifylline, a methylxanthine derivative and phospho diesterase inhibitor, inhibits the generation of mRNA for TN F-a in vitro [14] and decreases the in vivo production of TN F-a in humans and in experimental animals [15] [16] [17] . Pentoxifylline has been reported to increase survival of mice in endotoxic shock [16] , Chlorpromazine is a phenothiazine derivative with a broad spectrum of actions that protects against the toxicity o f endotoxin in various experimental models. At least part of this protection is achieved through inhibition of T N F synthesis [18] . Thalidomide has been used in the past as a sedative and antiemetic drug. Because of its teratogenic effects it has limited use as an antiinflammatory and immunosuppressive agent in the treatment of erythema nodosum leprosum, rheumatoid arthritis, and severe graftversus-host disease [19] [20] [21] . Thalidomide has been shown to inhibit TN F-a production by monocytes when these cells are triggered with endotoxin [22] .
In the present study, we evaluated to what extent treat ment with pentoxifylline, chlorpromazine, or thalidomide could increase survival after endotoxin challenge in sensi tized mice. We measured circulating concentrations ofTNFa, IL-1/3, and the two soluble T N F receptors, sTNFR-P55 and sTNFR-P75, after endotoxin challenge, We also evalu ated the effects of pentoxifylline, chlorpromazine and thali domide in lethal infections with Klebsiella pneumoniae or C. albicans. Because of the major importance of polymorphon uclear leukocytes in the defense against C. albicans [23] and their involvement in the actions of the cytokines during in fection, we studied the effects of the drugs in normal and neutropenic mice infected with C. albicans.
Materials and Methods
Animals. Female Swiss mice, 6-8 weeks old, weight 20-25 g, were obtained from a local colony. The animals were fed standard laboratory chow (Hope Farms, Woerden, Nether lands) and housed under specific pathogen-free conditions.
Drugs. Pentoxifylline was obtained from Hoechst Pharma (Frankfurt am Main, Germany). Chlorpromazine was obtained from Rhone-Poulenc Rorer (Amstelveen, Netherlands), and thalidomide was provided by K. Zwingenberger (Grunenthal, Sto 1 berg, Germany). Pentoxifylline (40 or 80 mg/kg) and chlorpromazine (4 mg/kg) were given in pyrogen-free saline by intraperitoneal (ip) injection, since this is a convenient and effective route for administration of these compounds [16, 18] . Because no water-soluble form of thalidomide is available, this drug was given by gastric instillation in 1% carboxymethylcellulose at a dose of 400 mg/kg, Control mice received vehicle by the same route. Pentoxifylline and chlorpromazine were given 30 min and thalidomide 1 h before endotoxin injection. In the experi ments with live microorganisms, all treatments were started 1 day before infection and continued daily thereafter, Pentoxifyl line was given at 80 mg/kg/day twice daily, chlorpromazine 4 mg/kg/day once daily, and thalidomide 400 mg/kg/day once daily.
Lethal endotoxemia in sensitized mice. Lipopolysaccharide (LPS; Escherichia co!i serotype 055:85) was obtained from Sigma (St. Louis). Mice were sensitized with actinomycin D (Sigma) or D-galactosamine (Merck, Darmstadt, Germany). An imals were injected ip with actinomycin D (0.6 or 0.8 mg/kg) 10 min before the ip injection of LPS (30 ^g/kg) as described [18] .
In the experiments in which the mice were sensitized with D-ga lactosamine, the animals were given D-galactosamine (560 mg/ kg) and LPS (40 MgAg) simultaneously ip [24] . After injection of LPS, 6 mice from each treatment group were anesthetized with ether and bled from the retroorbital plexus at 90 min for measurement of circulating TNF-a concentrations and another 6 mice per treatment group at 3 h for measurement of circulat ing concentrations of IL-1/3 and sTNFR-P55 and -P75, In the remaining mice, survival was assessed daily for 7 days.
K. pneumoniae infection. K. pneumoniae (ATCC 43816), a strain that produces a lethal infection in normal mice, was inocu lated in the left thigh muscle of the animals as described [25] . Tnocula ranged from 2 X 102 to 2 X 105 cfu. Twenty-four hours after infection, subgroups of mice were sacrificed and blood was collected for measurement of TNF-a plasma concentrations. To quantitate the recovery of the microorganisms from the livers and spleens, the organs were removed aseptically, weighed, and homogenized in sterile saline in a tissue grinder. To bring the bacterial counts after culture into the optimal range for reading, samples of liver and spleen were diluted in sterile saline. The suspensions were plated on sheep blood agar, and colony-form ing units were counted after overnight incubation. Survival of the animals was observed for 5 days after infection. In a separate experiment, the animals were infected with an inoculum of 104 cfu, and subgroups of 6 mice were sacrificed to measure TNF-a plasma concentrations at various time points after infection. In these animals, we measured the recovery of the microorganism from blood, liver, and spleen.
C. albicans infection. C. albicans (105 cfu) was given intrave nously (iv) in the lateral tail vein. At 24 h after injection, sub groups of mice were sacrificed, blood was taken for determina tion of plasma TNF-a concentrations, and the recovery of the microorganisms from livers, kidneys, and spleens was quanti tated in a manner similar to the quantitation of K. pneumoniae. Organ suspensions were plated on Sabouraud dextrose agar, and colonies were counted after overnight incubation. Survival of the animals was monitored for 8 days. In addition, mice ren dered granulocytopenic by subcutaneous injections of cyclo phosphamide, 150 mg/kg 4 days before and 100 mg/kg 1 day before infection, were injected with 104 cfu of C. albicans.
TNF-a measurement. Blood was collected in I-mL tubes containing 7.5 /igofEDTA (Becton Dickinson, Rutherford, NJ) and 250 ¡xL of aprotinin (Bayer, Leverkusen, Germany) and centrifuged for 5 min at 13,000 g. After separation, the plasma was stored at -20°C until assayed for TNF-a by ELISA. Briefly, 96-well immunoassay plates were coated overnight at 4°C with V 1Q, a rat monoclonal antibody specific for mouse TNF-a (pro vided by Peter Krammer, Institute for Immunology and Genet ics, German Cancer Research Center, Heidelberg) [26] . Nonoc cupied binding sites were blocked with \% bovine serum albumin. The samples were added onto the plate for 1 h at room temperature. A standard titration curve was obtained by serial dilutions of a known sample of recombinant mouse TNF-a in medium identical to the samples. Plates were then washed four times with wash buffer and incubated with a rabbit anti-mouse polyclonal antibody and peroxidase-conjugated swine anti-rab bit IgG. After substrate was added for 18 min, the reaction was stopped with 4 M H2S 04, and photospectrometry (450 nm) was done. The lower detection limit was 300 pg/mL. In some of the experiments, ELISA was done with TN3 as the monoclonal an tibody directed against mouse TNF-« as described [27] . TN3 was provided by Cell tech (Slough, UK) [28] .
IL-Jj3 measurement. Plasma was collected in the same man ner as for TNF-ct measurement. IL-1/3 was measured on plasma samples obtained 3 h after LPS injection by specific RIA as described [29] . sTNFR measurement. Plasma was collected in the same manner as for TNF-a measurement. sTNFR-P55 and sTNFR-P75 were measured in plasma samples obtained 3 h after LPS injection by specific ELISA as described [30] .
Statistical analysis. Survival curves were analyzed using the Kaplan-Meier logarithm of rank test [31] . Differences in con centrations of circulating cytokines and differences in organ counts of the microorganisms were analyzed using the Kruskal-Wallis test with x2 approximation. Results were considered sta tistically significant at P < .05.
Results
Lethal endotoxemia in sensitized mice. Mortality K. pneumoniae infection. At 30 min after intramuscular (im) injection o f 104 cfu of K. pneumoniae, blood cultures were still sterile, and TNF-a was not detectable in the circuwith chlorpromazine significantly improved survival (P < lation. However, at 90 min, TNF-a could be detected and .05), Treatment with pentoxifylline and thalidomide did not remained relatively constant during the observation period result in a better survival than control treatment (figure 1).
(concentration range, ]. 1-3.3 ng/mL); from this time point In a separate experiment in which treatment with pentoxifyl line was started 48 h before endotoxin challenge, survival of treated mice was not better than that of controls. Chlorpro mazine and pentoxifylline had a strong inhibitory effect on immunoreactive TNF-a concentrations in plasma 90 min after endotoxin, whereas thalidomide did not influence cir-on, the microorganisms were present in the blood, liver, and spleen, indicating that there was an ongoing sepsis in these animals.
Plasma TNF-a concentrations at 24 h after infection were significantly decreased in the groups treated with pentoxifyl line and chlorpromazine compared with controls. Pentoxi-A dilating TNF-a ( figure 2A) , In actinomycin D-sensitized fylline reduced TNF-a by 22% (from 0,9 ±0.1 to 0.7 ± 0.2 mice, TNF-a concentrations did not differ significantly be-ng/mL, n ~ 10, P < .05), and chlorpromazine reduced TNFtween the groups treated with pentoxifylline and chlorproma-a by 30% (0.5 ± 0.2 to 0.3 ± 0.07 ng/mL, n = 10, P < .05). zine, but in mice sensitized with D-galactosamine, TN F-a Although thalidomide reduced circulating T N F-a concenconcentrations in chlorpromazine-treated mice were signifi cantly lower than in pentoxifylline-treated mice (P < ,01; results not shown),
The effects of the drugs on circulating IL-1 ¡3 concentra tions 3 h after endotoxin injection is shown in figure 2B . Plasma IL-1/3 concentrations in chlorpromazine-treated mice were significantly lower than in control animals, but pentoxifylline and thalidomide did not influence circulating IL-1/3 concentrations.
None of the compounds influenced the concentrations of sTNFR-P55 3 h after endotoxin (not shown). However, chlorpromazine significantly decreased the concentration of sTNFR-P75 compared with controls ( figure 2C ). trations by 69%, this difference was not statistically signifi-ing TNF-a concentrations were substantially higher in neucant because of the large variation in the control group (con-tropenic mice than in nonneutropenic animals. Survival and trols, 1.3 ± 1.5; thalidomide treatment, 0.4 ± 0.1 ng/mL; n recovery of C. albicans from the organs were not influenced = 10).
by any of the drugs tested ( figure 4 ). Survival was not significantly improved by either drug. Bacterial counts tended to be lower in the livers and spleens of the treated animals, regardless of the drug used, but these Discussion differences did not consistently reach statistical significance. Because chlorpromazine had the strongest effect on bacterial counts, we investigated the antimicrobial effect of chlorpro mazine in vitro. Chlorpromazine did not inhibit the growth of K. pneumoniae in vitro (data not shown).
C. albicans infection in nonneutropenic mice. Plasma TNF-o: concentrations were lower in chlorpromazine-and thalidomide-treated animals than in their respective con trols, while pentoxifylline was not able to inhibit TNF-o; pro duction significantly during this infection ( figure 3A) . Sur vival was not influenced by any of the drugs used. Candidal outgrowth tended to be higher in pentoxifylline-and thalido mide-treated animals than in controls, but these differences were not statistically significant. However, chlorpromazinetreated animals showed significantly higher Candida counts in kidneys than did controls ( figure 4) .
C. albicans infection in neutropenic mice. Pentoxifylline significantly lowered plasma TNF-ct concentrations ( figure  3B ). Chlorpromazine and thalidomide tended to inhibit TNF-a synthesis (P = .065 and .07, respectively). Circulât- In this study we investigated the influence of three pharma cologic inhibitors of TNF-a synthesis on outcome of lethal endotoxemia and infection. Endotoxin-induced mortality was studied in mice sensitized with D-galactosamine or actinomycin D. Normal mice exhibit a low and varying sensitivity to endotoxin, thus hampering reproducibility of experi ments, Endotoxin-induced mortality in sensitized mice has been shown to be mediated by cytokine production [10, 18, 24] . To rule out specific effects of either D-galactosamine or actinomycin D, both compounds were used in experiments with sensitized mice. We found that chlorpromazine was the most powerful inhibitor of postendotoxin TNF-o: production and the only one that increased survival in lethal endotoxe mia. Despite substantial reduction in TN F-a production by pentoxifylline, this drug did not improve survival after endo toxin challenge in our experiments. Our findings with chlor promazine are in accordance with those of Gadina et al. [ 18] , but despite equal and even higher dosage schedules of pen toxifylline used in our experiments, we could not confirm the data ofSchade et al. [16] , who showed a beneficial effect of pentoxifylline on survival. These differences cannot readily be explained. Thalidomide appeared not to be an inhibitor of TNF-a production after in vivo administration of endotoxin. This finding underscores the differences in influ ence on cytokine production that may be observed in in vivo versus in vitro experiments [22] . However, thalidomide did decrease plasma TNF-o: concentrations after Candida infec tion in nonneutropenic mice. Differences in pharmacokinet ics between the orally administered thalidomide and ip chlor- promazine and pentoxifylline may account for these diver gent effects. Since pentoxifylline also substantially reduced postendo toxin circulating TNF-a concentrations, it is clear that re duction of TNF-a production cannot solely account for the beneficial effect ofchlorpromazine in lethal endotoxemia. In addition to substantially reducing TNF-a production, chlorpromazine profoundly decreased postendotoxin IL-10, and as far as we know this has not been reported before. As antag onism of IL-1 increases survival after lethal endotoxemia in mice [7] , interference wilh the production of this cytokine may contribute to the effects observed. Chlorpromazine has a wide range of pharmacologic activities, from antipsychotic and antihistaminic actions [32] to inhibition of phospholipase A2 [33] . To what extent these activities contribute to the effects in lethal endotoxemia is not clear. Pentoxifylline did not influence circulating IL-1/3 concentrations, a finding in accordance with reports that phosphodiesterase inhibitors, such as pentoxifylline, selectively decrease TNF-a: produc tion without affecting IL-1 production capacity [34] .
It is of interest that chlorpromazine strongly reduced the concentration of circulating sTNFR-P75 at 3 h after endo toxin, without affecting the concentration of circulating sTNFR-P55. It was recently reported that injection of endo toxin in mice results in an increase in both sTNFR-P55 and sTNFR-P75 as early as 30 min after the injection. sTNFR-P55 slowly diminished after a peak 30 min after LPS, whereas sTNFR-P75 increased to a plateau concentration 4-8 h after LPS administration [30] . Since both sTNFR-P55 and sTNFR-P75 are well detectable in plasma 3 h after LPS injection, it is unlikely that we missed a difference in sTNFR-p55 concentrations induced by one of the com pounds. Recently, evidence was gained that in mice, sTNFR-P75 and not sTNFR-p55 is responsible for the inac tivation of TNF and clearance of the cytokine from the circu lation [35] . It is unlikely that the strong decrease in sTNFR-P75 induced by chlorpromazine is brought about by its inhibiting effect on the production of TNF-a or IL-1/3, since neither anti-TNF antibody nor IL-1 receptor antagonist de creased the concentration of circulating sTNFR after endo toxin injection [30] . Thus, the mechanism by which chlor promazine reduces sTNFR-P75 concentration is probably more direct but remains to be elucidated.
From a clinical standpoint, it is somewhat worrisome that despite a marked inhibition of circulating TNF-a concentra tions, neither of the drugs we tested improved outcome in K. pneumoniae infection. An infection with live microorgan isms gives rise to a much more complicated response of the host than an injection of LPS. After LPS injection, circulat ing TNF-a concentrations peak at 90 min and decrease rap idly thereafter [2] . As shown here, there is an ongoing release of TNF after im injection of K. pneumoniae. These data are in accordance with the observations of others regarding the efficacy of anti-TNF antibodies in experimental E. coli infec tion: They may be protective after iv but not after ip injec tion of E. coli [36] . Thus, the lack o f an effect of pharmaco logic TNF inhibition is reminiscent of the inability of anti-TNF antibodies to improve outcome in animal models of infection that resemble the gram-negative infection we have studied [4, 26, 37] .
In C. albicans infection in mice, we found no influence of the three drugs on the survival of the animals. A recent study also failed to show an effect of pentoxifylline on outcome o f infection wilh C. albicans in rats [17] . In our pentoxifyllinetreated nonneutropenic mice, the concentrations o f TN F-a tended to be reduced, but they were significantly inhibited only in the chlorpromazine-and thalidomide-treated groups. Only pentoxifylline significantly affected T N F-a concentra tions in neutropenic mice. Since the same doses of pentoxi fylline and chlorpromazine did decrease T N F -a synthesis in K. pneumoniae infection, these differences may be due to differences in the regulation of TN F-a production in the two infection models. In this respect it should be mentioned that endotoxin does not induce TNF-a synthesis in endotoxin-resistant C3H/HeJ mice, while C. albicans does [13] .
In nonneutropenic mice, chlorpromazine treatment was associated with an increased outgrowth o f candidae from the kidneys, However, in neutropenic mice, none o f the drugs tested influenced the recovery of the microorganisms from the organs. This observation is in accordance with the report by Steinshamn and Waage [38] , who found that treatment with a monoclonal antibody against T N F-a increased out growth of C albicans from the kidneys of normal but not of neutropenic mice. Taken together, these observations in in fection models are in agreement with the observations that TNF-a increases the intracellular killing of C albicans by neutrophils in vitro [39, 40] . Apart from its influence on TNF production, direct interference with killing function of neutrophils may also play a role in the increased candidal outgrowth in chlorpromazine-treated mice [41] [42] [43] .
We conclude that chlorpromazine protects sensitized mice against death due to lethal endotoxemia and that this protec tion is accompanied by a strong inhibition of in vivo TN F-a and IL-10 synthesis. The anticytokine effect ofchlorprom a zine may be counteracted by decreased concentrations of circulating sTNFR-P75. Pentoxifylline, chlorpromazine, and thalidomide do not improve survival in the models of bacterial and fungal infections studied. In experimental in fections, which are probably more relevant for infections in humans than are LPS challenges, the capacity of the drugs tested to inhibit TNF-a production appeared limited, in the case of chlorpromazine, the potential benefit of reducing cir culating concentrations of TNF-a: in lethal infections seems to be counteracted by a reduced phagocytosing capacity of neutrophils. In these experimental infections, the effects of pharmacologic inhibition of TNF~<* production are reminis cent of the effects observed with antibodies to TNF-a.
